IV 주입 약제 기기 시장 - 제품 유형, 최종사용자, 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2023-2030년)

Persistence Market Research, a renowned market research firm, has recently released an insightful report on the global IV Fluid Transfer Drug Devices Market. This comprehensive analysis offers valuable insights into key market dynamics, growth drivers, challenges, and emerging trends. The report provides a detailed overview of the IV fluid transfer drug devices industry, featuring exclusive data and statistics projecting the market's growth trajectory from 2023 to 2030.

The global IV fluid transfer drug devices market is forecast to expand at a CAGR of 3.5% and thereby increase from a value of US$6.7 Bn in 2023, to US$8.5 Bn by the end of 2030.

Key Insights:

• IV Fluid Transfer Drug Devices Market Size (2023): US$6.7 Bn
• Projected Market Value (2030): US$8.5 Bn
• Global Market Growth Rate (CAGR 2023 to 2030): 3.5%
• Historical Market Growth Rate (CAGR 2018 to 2022): 2.3%

IV Fluid Transfer Drug Devices Market - Report Scope:

The IV Fluid Transfer Drug Devices Market is poised for significant growth, driven by the increasing prevalence of chronic diseases, the rising demand for home healthcare solutions, and advancements in drug delivery technologies. This market serves healthcare institutions, homecare settings, and pharmaceutical manufacturers, offering a range of IV fluid transfer devices designed for safe and efficient drug administration. Market growth is fueled by the aging population, the growing incidence of chronic conditions, and the expansion of telemedicine and remote patient monitoring services.

Market Growth Drivers:

The global IV Fluid Transfer Drug Devices Market benefits from several key growth drivers. The growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, coupled with the aging population and increasing healthcare expenditure, drives market expansion. IV fluid transfer devices offer convenience, flexibility, and accuracy in drug administration, enhancing patient compliance and treatment outcomes. Moreover, advancements in infusion pump technologies, smart infusion systems, and wearable drug delivery devices enable personalized and continuous therapy monitoring. The market is also influenced by the expansion of home infusion services, the rise of specialty pharmaceuticals, and the adoption of value-based healthcare models.

Market Restraints:

Despite promising growth prospects, the IV Fluid Transfer Drug Devices Market faces challenges related to regulatory compliance, reimbursement policies, and patient safety concerns. Stringent regulations governing the design, manufacturing, and marketing of medical devices impose compliance burdens on manufacturers and healthcare providers. Additionally, reimbursement limitations for home infusion therapy and specialty drugs may hinder market penetration. Furthermore, concerns related to medication errors, drug interactions, and infusion pump malfunctions impact patient safety and trust in IV fluid transfer devices. Addressing these barriers requires collaboration between industry stakeholders, regulatory authorities, and healthcare payers to ensure patient access to safe and effective drug delivery solutions.

Market Opportunities:

The IV Fluid Transfer Drug Devices Market presents significant growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The integration of digital health technologies, such as wireless connectivity, remote monitoring, and smart sensors, enhances patient access to IV therapy and improves treatment adherence and outcomes. Furthermore, the expansion of home infusion services, ambulatory infusion centers, and specialty pharmacy networks broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of user-friendly, cost-effective drug delivery devices are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic landscape of IV therapy.

Key Questions Answered in the Report:

• What is the Forecast CAGR of the Global IV Fluid Transfer Drug Devices Market?
• What was the Market Size in the Year 2023?
• Which Country Held the Largest Market Share in 2023?
• Who are the Key Players in the Global IV Fluid Transfer Drug Devices Market?
• Which is the Fastest-growing Segment of the Market by Application?

Competitive Intelligence and Business Strategy:

Leading players in the global IV Fluid Transfer Drug Devices Market, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in the development of advanced infusion pumps, drug delivery systems, and infusion sets, exploring novel materials and wireless connectivity options to enhance device functionality and user experience. Collaborations with healthcare providers, home infusion companies, and specialty pharmacies facilitate market access and improve the adoption of IV fluid transfer devices. Moreover, emphasis on patient education, training programs, and 24/7 technical support services fosters market growth and enhances patient safety in the rapidly evolving landscape of home infusion therapy and specialty drug administration.

Key Companies Profiled:

• Advance Medical Designs Inc.
• B. Braun Medical
• Baxter Healthcare
• ICU Medical Inc.
• Hospira
• Q.I. Medical Inc.
• Pfizer
• Unilife Corporation
• Amedra Pharmaceuticals
• Sanofi
• Biogen Idec
• BIONIK Laboratories Corp.
• Ekso Bionics Holdings Inc.

IV Fluid Transfer Drug Devices Market Research Segmentation:

Oncology stands out as the leading application driving global market growth in IV fluid transfer drug devices. The significant increase in the oncology category is attributed to the rising incidence of cancer and the growing use of intravenous chemotherapy treatments, where IV fluid transfer devices play a crucial role in delivering accurate dosages.

The fastest-growing market segment is neurology, fueled by the increasing prevalence of neurological illnesses worldwide. The demand for intravenous therapies in neurology, including drug administration for conditions such as neuropathic pain and multiple sclerosis, drives the rapid rise of this market sector.

Hospitals dominate the end-user segment due to their large patient volumes, diverse medical needs, and the essential role IV treatments play in acute and critical care settings. Specialist clinics represent the fastest-growing market category, driven by the rise in outpatient care and the demand for focused and customized treatments.

North America maintains dominance in the IV fluid transfer drug devices market, driven by its advanced healthcare technologies, substantial healthcare expenditure, and strong regulatory framework. The region's proactive adoption of cutting-edge healthcare technologies and the increasing prevalence of chronic diseases contribute to the high demand for IV fluid transfer devices. In contrast, the IV fluid transfer drug devices market is expanding rapidly in East Asia, propelled by rapid economic development, rising healthcare awareness, and a growing demand for advanced medical treatments in countries like China, Japan, and South Korea.

By Application:

• Autoimmune Diseases
• Blood Disorders
• Cardiovascular Disorders
• Neurology
• Oncology
• Others

By End User:

• Hospitals
• Specialized Clinics
• Others

By Region:

• North America
• Europe
• East Asia
• South Asia & Oceania
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global IV Fluid Transfer Drug Devices Market Snapshot, 2023 and 2030
• 1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Challenges
  • 2.2.5. Key Trends
• 2.3. Application Lifecycle Analysis
• 2.4. IV Fluid Transfer Drug Devices Market: Value Chain
  • 2.4.1. List of Raw Material Supplier
  • 2.4.2. List of Manufacturers
  • 2.4.3. List of Distributors
  • 2.4.4. List of Applications
  • 2.4.5. Profitability Analysis
• 2.5. Porter Five Force's Analysis
• 2.6. Geopolitical Tensions: Market Impact
• 2.7. Macro-Economic Factors
  • 2.7.1. Global Sectorial Outlook
  • 2.7.2. Global GDP Growth Outlook
  • 2.7.3. Global Parent Market Overview
• 2.8. Forecast Factors - Relevance and Impact
• 2.9. Regulatory and Technology Landscape

3. Global IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 3.1. Key Highlights
  • 3.1.1. Market Volume (Units) Projections
  • 3.1.2. Market Size and Y-o-Y Growth
  • 3.1.3. Absolute $ Opportunity
• 3.2. Market Size (US$ Mn) Analysis and Forecast
  • 3.2.1. Historical Market Size Analysis, 2013-2016
  • 3.2.2. Current Market Size Forecast, 2018-2026
• 3.3. Global IV Fluid Transfer Drug Devices Market Outlook: Application
  • 3.3.1. Introduction / Key Findings
  • 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
  • 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
    • 3.3.3.1. Autoimmune Diseases
    • 3.3.3.2. Blood Disorders
    • 3.3.3.3. Cardiovascular Disorders
    • 3.3.3.4. Neurology
    • 3.3.3.5. Oncology
    • 3.3.3.6. Others
• 3.4. Market Attractiveness Analysis: Application
• 3.5. Global IV Fluid Transfer Drug Devices Market Outlook: End User
  • 3.5.1. Introduction / Key Findings
  • 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End User, 2018 - 2022
  • 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
    • 3.5.3.1. Hospitals
    • 3.5.3.2. Specialized Clinics
    • 3.5.3.3. Others
• 3.6. Market Attractiveness Analysis: End User

4. Global IV Fluid Transfer Drug Devices Market Outlook: Region

• 4.1. Key Highlights
• 4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
• 4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
  • 4.3.1. North America
  • 4.3.2. Europe
  • 4.3.3. East Asia
  • 4.3.4. South Asia and Oceania
  • 4.3.5. Latin America
  • 4.3.6. Middle East & Africa (MEA)
• 4.4. Market Attractiveness Analysis: Region

5. North America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 5.1. Key Highlights
• 5.2. Pricing Analysis
• 5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 5.3.1. By Country
  • 5.3.2. By Application
  • 5.3.3. By End User
• 5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 5.4.1. U.S.
  • 5.4.2. Canada
• 5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  • 5.5.1. Autoimmune Diseases
  • 5.5.2. Blood Disorders
  • 5.5.3. Cardiovascular Disorders
  • 5.5.4. Neurology
  • 5.5.5. Oncology
  • 5.5.6. Others
• 5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 5.6.1. Hospitals
  • 5.6.2. Specialized Clinics
  • 5.6.3. Others
• 5.7. Market Attractiveness Analysis

6. Europe IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 6.1. Key Highlights
• 6.2. Pricing Analysis
• 6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 6.3.1. By Country
  • 6.3.2. By Application
  • 6.3.3. By End User
• 6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 6.4.1. Germany
  • 6.4.2. France
  • 6.4.3. U.K.
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Russia
  • 6.4.7. Turkiye
  • 6.4.8. Rest of Europe
• 6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  • 6.5.1. Autoimmune Diseases
  • 6.5.2. Blood Disorders
  • 6.5.3. Cardiovascular Disorders
  • 6.5.4. Neurology
  • 6.5.5. Oncology
  • 6.5.6. Others
• 6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 6.6.1. Hospitals
  • 6.6.2. Specialized Clinics
  • 6.6.3. Others
• 6.7. Market Attractiveness Analysis

7. East Asia IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 7.1. Key Highlights
• 7.2. Pricing Analysis
• 7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 7.3.1. By Country
  • 7.3.2. By Application
  • 7.3.3. By End User
• 7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 7.4.1. China
  • 7.4.2. Japan
  • 7.4.3. South Korea
• 7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  • 7.5.1. Autoimmune Diseases
  • 7.5.2. Blood Disorders
  • 7.5.3. Cardiovascular Disorders
  • 7.5.4. Neurology
  • 7.5.5. Oncology
  • 7.5.6. Others
• 7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 7.6.1. Hospitals
  • 7.6.2. Specialized Clinics
  • 7.6.3. Others
• 7.7. Market Attractiveness Analysis

8. South Asia & Oceania IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 8.1. Key Highlights
• 8.2. Pricing Analysis
• 8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 8.3.1. By Country
  • 8.3.2. By Application
  • 8.3.3. By End User
• 8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 8.4.1. India
  • 8.4.2. Southeast Asia
  • 8.4.3. ANZ
  • 8.4.4. Rest of South Asia & Oceania
• 8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  • 8.5.1. Autoimmune Diseases
  • 8.5.2. Blood Disorders
  • 8.5.3. Cardiovascular Disorders
  • 8.5.4. Neurology
  • 8.5.5. Oncology
  • 8.5.6. Others
• 8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 8.6.1. Hospitals
  • 8.6.2. Specialized Clinics
  • 8.6.3. Others
• 8.7. Market Attractiveness Analysis

9. Latin America IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 9.1. Key Highlights
• 9.2. Pricing Analysis
• 9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 9.3.1. By Country
  • 9.3.2. By Application
  • 9.3.3. By End User
• 9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America
• 9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  • 9.5.1. Autoimmune Diseases
  • 9.5.2. Blood Disorders
  • 9.5.3. Cardiovascular Disorders
  • 9.5.4. Neurology
  • 9.5.5. Oncology
  • 9.5.6. Others
• 9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 9.6.1. Hospitals
  • 9.6.2. Specialized Clinics
  • 9.6.3. Others
• 9.7. Market Attractiveness Analysis

10. Middle East & Africa IV Fluid Transfer Drug Devices Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

• 10.1. Key Highlights
• 10.2. Pricing Analysis
• 10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
  • 10.3.1. By Country
  • 10.3.2. By Application
  • 10.3.3. By End User
• 10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
  • 10.4.1. GCC
  • 10.4.2. Egypt
  • 10.4.3. South Africa
  • 10.4.4. Northern Africa
  • 10.4.5. Rest of Middle East & Africa
• 10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  • 10.5.1. Autoimmune Diseases
  • 10.5.2. Blood Disorders
  • 10.5.3. Cardiovascular Disorders
  • 10.5.4. Neurology
  • 10.5.5. Oncology
  • 10.5.6. Others
• 10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By End User, 2023 - 2030
  • 10.6.1. Hospitals
  • 10.6.2. Specialized Clinics
  • 10.6.3. Others
• 10.7. Market Attractiveness Analysis

11. Competition Landscape

• 11.1. Market Share Analysis, 2022
• 11.2. Market Structure
  • 11.2.1. Competition Intensity Mapping By Market
  • 11.2.2. Competition Dashboard
  • 11.2.3. Apparent Application Capacity
• 11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 11.3.1. Advance Medical Designs Inc.
    • 11.3.1.1. Overview
    • 11.3.1.2. Segments and Application
    • 11.3.1.3. Key Financials
    • 11.3.1.4. Market Developments
    • 11.3.1.5. Market Strategy
  • 11.3.2. B. Braun Medical
    • 11.3.2.1. Overview
    • 11.3.2.2. Segments and Application
    • 11.3.2.3. Key Financials
    • 11.3.2.4. Market Developments
    • 11.3.2.5. Market Strategy
  • 11.3.3. Baxter Healthcare
    • 11.3.3.1. Overview
    • 11.3.3.2. Segments and Application
    • 11.3.3.3. Key Financials
    • 11.3.3.4. Market Developments
    • 11.3.3.5. Market Strategy
  • 11.3.4. ICU Medical Inc.
    • 11.3.4.1. Overview
    • 11.3.4.2. Segments and Application
    • 11.3.4.3. Key Financials
    • 11.3.4.4. Market Developments
    • 11.3.4.5. Market Strategy
  • 11.3.5. Hospira
    • 11.3.5.1. Overview
    • 11.3.5.2. Segments and Application
    • 11.3.5.3. Key Financials
    • 11.3.5.4. Market Developments
    • 11.3.5.5. Market Strategy
  • 11.3.6. Q.I. Medical Inc.
    • 11.3.6.1. Overview
    • 11.3.6.2. Segments and Application
    • 11.3.6.3. Key Financials
    • 11.3.6.4. Market Developments
    • 11.3.6.5. Market Strategy
  • 11.3.7. Pfizer
    • 11.3.7.1. Overview
    • 11.3.7.2. Segments and Application
    • 11.3.7.3. Key Financials
    • 11.3.7.4. Market Developments
    • 11.3.7.5. Market Strategy
  • 11.3.8. Unilife Corporation
    • 11.3.8.1. Overview
    • 11.3.8.2. Segments and Application
    • 11.3.8.3. Key Financials
    • 11.3.8.4. Market Developments
    • 11.3.8.5. Market Strategy
  • 11.3.9. Amedra Pharmaceuticals
    • 11.3.9.1. Overview
    • 11.3.9.2. Segments and Application
    • 11.3.9.3. Key Financials
    • 11.3.9.4. Market Developments
    • 11.3.9.5. Market Strategy
  • 11.3.10. Sanofi
    • 11.3.10.1. Overview
    • 11.3.10.2. Segments and Application
    • 11.3.10.3. Key Financials
    • 11.3.10.4. Market Developments
    • 11.3.10.5. Market Strategy
  • 11.3.11. Biogen Idec
    • 11.3.11.1. Overview
    • 11.3.11.2. Segments and Application
    • 11.3.11.3. Key Financials
    • 11.3.11.4. Market Developments
    • 11.3.11.5. Market Strategy
  • 11.3.12. BIONIK Laboratories Corp.
    • 11.3.12.1. Overview
    • 11.3.12.2. Segments and Application
    • 11.3.12.3. Key Financials
    • 11.3.12.4. Market Developments
    • 11.3.12.5. Market Strategy
  • 11.3.13. Ekso Bionics Holdings Inc.
    • 11.3.13.1. Overview
    • 11.3.13.2. Segments and Application
    • 11.3.13.3. Key Financials
    • 11.3.13.4. Market Developments
    • 11.3.13.5. Market Strategy

12. Appendix

• 12.1. Research Methodology
• 12.2. Research Assumptions
• 12.3. Acronyms and Abbreviations